Description
| Product Name | Format | CAT.No | Size |
| CK-MB Immunoinhibition | LS | BXC0451A | R1: 1 x 35ml R2: 10 x 2.5ml R3: 1 x 2ml |
| CK-MB Immunoinhibition | LS | BXC0451B | R1: 1 x 105ml R2: 10 x 10ml R3: 1 x 2ml |
| CK-MB Immunoinhibition | LS | BXC0451C | R1: 1 x 15ml R2: 2 x 2.5ml R3: 1 x 2ml |
| CK-MB Enzymatic UV | LS | BXC0452A | R1: 1 x 25ml R2: 1 x 5ml |
| CK-MB Enzymatic UV | LS | BXC0452B | R1: 2 x 25ml R2: 2 x 5ml |
| CK-MB Enzymatic UV | LS | BXC0452C | R1: 10 x 3ml R2: 1 x 6ml |
| CK-MB Enzymatic UV | LS | BXC0452T | R1: 2 X 50ml R2: 2 X 10ml |
| CK-MB 4+1 | LS | BXC0458A | R1: 1 x 20ml R2: 1 x 4ml |
| CK-MB 4+1 | LS | BXC0458B | R1: 2 x 20ml R2: 1 x 10ml |
Product Description
The Biorex Diagnostics CK-MB Assay is a ready-to-use reagent system for the quantitative determination of CK-MB in human serum or plasma. CK-MB testing is a clinically essential tool for diagnosing myocardial ischaemia, acute myocardial infarction, and monitoring cardiac injury.
Key Features
• Quantitative measurement of CK-MB in serum and plasma
• Clinically relevant for early diagnosis and monitoring of myocardial infarction and cardiac events
• Highly specific immunoinhibition or enzymatic method ensures accuracy and reproducibility
• Ready-to-use reagents simplify workflow and reduce preparation errors
• Compatible with automated analysers, kinetic assays, and manual laboratory methods
Benefits
The Biorex CK-MB Assay provides precise and reliable results for cardiac event diagnosis, myocardial injury monitoring, and clinical research. Its ready-to-use format and robust methodology streamline laboratory workflow while delivering essential information for effective patient management and cardiac care.